SRTS logo

SENSUS HEALTHCARE INC

SRTSNASDAQ
πŸ† #4312 by market capEarnings Oct 29 Β· PostUS Equity
$2.84β–Ό $0.11 (βˆ’3.73%)
Latest quote
πŸ””
Track SRTS
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 3.7%
7dβ–Ό 0.7%
14dβ–² 2.5%
30dβ–Ό 5.6%
ytdβ–Ό 27.7%
1yβ–Ό 12.6%
🏦Market Cap
$47M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-53.4%
Declining
πŸ“ŠGross Margin
36.4%
Healthy
πŸ’΅FCF Margin
30.7%
Strong
βš–οΈP/S Ratio
2.7x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$2.75 – $2.84
52-Week Range
$2.66 – $5.49
Volume (shares)
232
Avg Volume (shares)
β€”
Shares Outstanding
16.5M
Next Earnings
2026-10-29

Fundamentals Snapshot

Annual Revenue
$27M
Last Q Revenue
$2M
P/E Ratio
β€”
P/S Ratio
2.7x
EPS (TTM)
$-0.94
Dividend Yield
β€”
Dilution (1yr)
βˆ’0.7%
SRTS logo

SENSUS HEALTHCARE INC

SRTS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$27Mβ–Ό βˆ’34.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
43.2%β–Ό βˆ’26.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$10Mβ–Ό βˆ’227.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$332Kβ–Ό βˆ’130.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
16.3Mβ–Ό βˆ’0.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$21Mβ–Ό βˆ’$51K YoY
StockOtter Β· stockotter.space

About SENSUS HEALTHCARE INC

Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Buy
10 analysts
Strong Buy2
Buy7
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.